Another pharmaceutical patent refusal came under the judicial
scanner in the Calcutta High Court. This time, a patent application
filed by Oramed Ltd. for a novel oral insulin composition aimed at
eliminating the need for daily insulin injections was refused by
the Deputy Controller for lack of inventive step and composition
falling under Section 3(e) of the Patents Act. Aggrieved by this
refusal, the applicant filed an appeal before the Calcutta High
Court [IPDPTA/8/2022] (OA/14/2020/PT/KOL).
In Oramed Ltd. vs the Controller General of
Patents, the Calcutta High Court set aside the
decision vide order dated July 4, 2025, and remanded the case for a
fresh hearing before a different Controller. This case was remanded
earlier by the Calcutta High Court vide its order dated June 19,
2019, passed in the Writ Petition No. WP (9575) of 2019.
Significantly, in that order, this Court had directed the
respondent to consider all materials made available and filed by
the
